Cargando…

Plant Viral Nanoparticle Conjugated with Anti-PD-1 Peptide for Ovarian Cancer Immunotherapy

Immunotherapy holds tremendous potential in cancer therapy, in particular, when treatment regimens are combined to achieve synergy between pathways along the cancer immunity cycle. In previous works, we demonstrated that in situ vaccination with the plant virus cowpea mosaic virus (CPMV) activates a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gautam, Aayushma, Beiss, Veronique, Wang, Chao, Wang, Lu, Steinmetz, Nicole F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467759/ https://www.ncbi.nlm.nih.gov/pubmed/34575893 http://dx.doi.org/10.3390/ijms22189733

Ejemplares similares

In situ vaccine application of inactivated CPMV nanoparticles for cancer immunotherapy
por: Chariou, Paul L., et al.
Publicado: (2021)

Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy
por: Kerstetter-Fogle, Amber, et al.
Publicado: (2019)

Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications
por: Chung, Young Hun, et al.
Publicado: (2020)

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death
por: Moon, Yujeong, et al.
Publicado: (2022)

Remission-Stage Ovarian Cancer Cell Vaccine with Cowpea Mosaic Virus Adjuvant Prevents Tumor Growth
por: Stump, Courtney T., et al.
Publicado: (2021)

Cowpea Mosaic Virus Nanoparticle Enhancement of Hypofractionated Radiation in a B16 Murine Melanoma Model
por: Duval, Kayla E. A., et al.
Publicado: (2020)

In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade
por: Mao, Chenkai, et al.
Publicado: (2022)

An enzyme-responsive and transformable PD-L1 blocking peptide-photosensitizer conjugate enables efficient photothermal immunotherapy for breast cancer
por: Sun, Yanan, et al.
Publicado: (2022)

Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal
por: Wang, Zhenqing, et al.
Publicado: (2021)

All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy
por: Song, Sukyung, et al.
Publicado: (2023)

Three methods for inoculation of viral vectors into plants
por: Monroy-Borrego, Andrea G., et al.
Publicado: (2022)

Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1
por: Chardin, Laure, et al.
Publicado: (2021)

Role of Anti-PD-1 Antibodies in Advanced Melanoma: The Era of Immunotherapy
por: Sahni, Sakshi, et al.
Publicado: (2018)

Active recruitment of anti–PD-1–conjugated platelets through tumor-selective thrombosis for enhanced anticancer immunotherapy
por: Wang, Yixin, et al.
Publicado: (2023)

Enhanced anti-tumor immunotherapy by silica-coated magnetic nanoparticles conjugated with ovalbumin
por: Lee, Sung-Ju, et al.
Publicado: (2019)

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes
por: Tatovic, D, et al.
Publicado: (2022)

Effect of peptide-conjugated nanoparticles on cell lines
por: Banerjee, Kangkana, et al.
Publicado: (2019)

Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy
por: Liu, Hao, et al.
Publicado: (2019)

Multivalent Peptide–Nanoparticle Conjugates for Influenza‐Virus Inhibition
por: Lauster, Daniel, et al.
Publicado: (2017)

Polymer chimera of stapled oncolytic peptide coupled with anti-PD-L1 peptide boosts immunotherapy of colorectal cancer
por: Lu, Lu, et al.
Publicado: (2022)

Plant expression and characterization of the transmission-blocking vaccine candidate PfGAP50
por: Beiss, Veronique, et al.
Publicado: (2015)

A d-peptide-based oral nanotherapeutic modulates the PD-1/PD-L1 interaction for tumor immunotherapy
por: Liu, Dan, et al.
Publicado: (2023)

Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers
por: Heiniö, Camilla, et al.
Publicado: (2022)

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy
por: Hingorani, Dina V., et al.
Publicado: (2022)

Transcriptomics of Canine Inflammatory Mammary Cancer Treated with Empty Cowpea Mosaic Virus Implicates Neutrophils in Anti-Tumor Immunity
por: Barreno, Lucia, et al.
Publicado: (2023)

Editorial: Peptide-based immunotherapy against emerging viral infections
por: Jiang, Shisong
Publicado: (2023)

Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis
por: Guo, Weinan, et al.
Publicado: (2022)

Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer
por: Baron, Marine, et al.
Publicado: (2022)

Combination of an autophagy inhibitor with immunoadjuvants and an anti-PD-L1 antibody in multifunctional nanoparticles for enhanced breast cancer immunotherapy
por: Cheng, Yibin, et al.
Publicado: (2022)

Anti-PD-L1 F(ab) Conjugated PEG-PLGA Nanoparticle Enhances Immune Checkpoint Therapy
por: Lee, Christina K., et al.
Publicado: (2022)

Novel Approaches in the Immunotherapy of Multiple Sclerosis: Cyclization of Myelin Epitope Peptides and Conjugation with Mannan
por: Matsoukas, John M., et al.
Publicado: (2021)

Cowpea Mosaic Virus Immunotherapy Combined with Cyclophosphamide Reduces Breast Cancer Tumor Burden and Inhibits Lung Metastasis
por: Cai, Hui, et al.
Publicado: (2019)

Immunotherapy of Ovarian Cancer with Particular Emphasis on the PD-1/PDL-1 as Target Points
por: Świderska, Janina, et al.
Publicado: (2021)

Research advances in peptide‒drug conjugates
por: Gong, Liming, et al.
Publicado: (2023)

Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients
por: Valdivia, Guillermo, et al.
Publicado: (2023)

Synthesis of aryl-thioglycopeptides through chemoselective Pd-mediated conjugation
por: Montoir, David, et al.
Publicado: (2018)

Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles
por: Rangger, Christine, et al.
Publicado: (2013)

Multifunctional Peptide-Conjugated Hybrid Silica Nanoparticles for Photodynamic Therapy and MRI
por: Benachour, Hamanou, et al.
Publicado: (2012)

Peptide–nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms?
por: Jeong, Woo-jin, et al.
Publicado: (2018)

Catalytically Active Peptide–Gold Nanoparticle Conjugates: Prospecting for Artificial Enzymes
por: Mikolajczak, Dorian J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5d7s8l7air7tjbak2nbbvjargq